These final results, along with a previous report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two aid the thought of targeting ACKR3 as a singular strategy to modulate the opioid technique, which could open up new therapeutic avenues for opioid-associated Conditions. A investigation review posted https://giordanof147pmi7.wikiexcerpt.com/user